Earnings and Valuation
This table compares Atlantic International and its competitors revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Atlantic International | $80,000.00 | -$5.63 million | -0.28 |
Atlantic International Competitors | $3.15 billion | $43.38 million | -14.46 |
Atlantic International’s competitors have higher revenue and earnings than Atlantic International. Atlantic International is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Volatility and Risk
Atlantic International has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, Atlantic International’s competitors have a beta of 1.14, suggesting that their average stock price is 14% more volatile than the S&P 500.
Institutional and Insider Ownership
Profitability
This table compares Atlantic International and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Atlantic International | N/A | -298.20% | -42.32% |
Atlantic International Competitors | -0.66% | 15.30% | 4.24% |
Summary
Atlantic International competitors beat Atlantic International on 5 of the 9 factors compared.
About Atlantic International
Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.
Receive News & Ratings for Atlantic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlantic International and related companies with MarketBeat.com's FREE daily email newsletter.